MX2019006825A - Uso de andamios biológicos de arn mediante selección in vitro para la generación de moléculas de aptámeros, con robusta capacidad de unión a biosensores genéticamente codificables. - Google Patents

Uso de andamios biológicos de arn mediante selección in vitro para la generación de moléculas de aptámeros, con robusta capacidad de unión a biosensores genéticamente codificables.

Info

Publication number
MX2019006825A
MX2019006825A MX2019006825A MX2019006825A MX2019006825A MX 2019006825 A MX2019006825 A MX 2019006825A MX 2019006825 A MX2019006825 A MX 2019006825A MX 2019006825 A MX2019006825 A MX 2019006825A MX 2019006825 A MX2019006825 A MX 2019006825A
Authority
MX
Mexico
Prior art keywords
biosensors
codificable
aptameral
scaffolding
genetically
Prior art date
Application number
MX2019006825A
Other languages
English (en)
Spanish (es)
Inventor
T Batey Robert
B Porter Ely
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of MX2019006825A publication Critical patent/MX2019006825A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/28Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Vibrionaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1044Preparation or screening of libraries displayed on scaffold proteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1058Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1093General methods of preparing gene libraries, not provided for in other subgroups
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/111General methods applicable to biologically active non-coding nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/04Libraries containing only organic compounds
    • C40B40/06Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/10Type of nucleic acid
    • C12N2310/16Aptamers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/50Physical structure
    • C12N2310/53Physical structure partially self-complementary or closed
    • C12N2310/531Stem-loop; Hairpin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2320/00Applications; Uses
    • C12N2320/10Applications; Uses in screening processes
    • C12N2320/11Applications; Uses in screening processes for the determination of target sites, i.e. of active nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2330/00Production
    • C12N2330/30Production chemically synthesised
    • C12N2330/31Libraries, arrays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Ecology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MX2019006825A 2016-12-12 2017-12-11 Uso de andamios biológicos de arn mediante selección in vitro para la generación de moléculas de aptámeros, con robusta capacidad de unión a biosensores genéticamente codificables. MX2019006825A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662432879P 2016-12-12 2016-12-12
PCT/US2017/065526 WO2018111745A1 (en) 2016-12-12 2017-12-11 Use of biological rna scaffolds with in vitro selection to generate robust small molecule binding aptamers for genetically encodable biosensors

Publications (1)

Publication Number Publication Date
MX2019006825A true MX2019006825A (es) 2019-10-30

Family

ID=62559449

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019006825A MX2019006825A (es) 2016-12-12 2017-12-11 Uso de andamios biológicos de arn mediante selección in vitro para la generación de moléculas de aptámeros, con robusta capacidad de unión a biosensores genéticamente codificables.

Country Status (14)

Country Link
US (2) US20200208142A1 (enExample)
EP (1) EP3551755A4 (enExample)
JP (2) JP7418210B2 (enExample)
KR (1) KR102612226B1 (enExample)
CN (1) CN110462039A (enExample)
AU (1) AU2017378078B2 (enExample)
BR (1) BR112019012012A2 (enExample)
CA (1) CA3056218A1 (enExample)
EA (1) EA201991446A1 (enExample)
IL (1) IL267216B2 (enExample)
MX (1) MX2019006825A (enExample)
MY (1) MY205553A (enExample)
PH (1) PH12019501302A1 (enExample)
WO (1) WO2018111745A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10852274B2 (en) 2017-03-09 2020-12-01 Auburn University Differential circuit for background correction in electrochemical measurements
US11505799B2 (en) 2017-07-07 2022-11-22 Innamed, Inc. Aptamers for measuring lipoprotein levels
US11560565B2 (en) 2018-06-13 2023-01-24 Auburn University Electrochemical detection nanostructure, systems, and uses thereof
WO2020264444A2 (en) * 2019-06-27 2020-12-30 Innamed, Inc. Assay method for point of care quantification of an immunophilin-binding immunosuppressant drug
CN113430203A (zh) * 2020-03-23 2021-09-24 华东理工大学 一种新型rna检测与定量的方法
WO2021256582A1 (ko) * 2020-06-17 2021-12-23 포항공과대학교 산학협력단 전사 활성 인자 및 토홀드 스위치를 포함하는 트립토판 검출용 바이오센서
WO2022006042A1 (en) * 2020-06-29 2022-01-06 President And Fellows Of Harvard College Methods, compositions, and kits for nucleic acid barcoding of biomolecules
CN115177740A (zh) * 2021-04-01 2022-10-14 安升(上海)医药科技有限公司 核酸自组装介导的adc药物的构建方法及应用
CN113512089B (zh) * 2021-06-30 2023-06-13 兰州大学 一种水溶性量子点的多肽稳定剂及应用
CN115704029A (zh) * 2021-08-06 2023-02-17 纳莹(上海)生物科技有限公司 一种rna检测与定量的方法
CN114518359B (zh) * 2022-03-08 2024-08-20 山东理工大学 一种基于g-四联体的双模式卡那霉素适配体传感器的制备方法
CN115791726B (zh) * 2022-11-25 2024-11-15 海南大学 一种基于g-四联体dna超灵敏高选择性检测锶离子的方法
WO2024118806A1 (en) * 2022-11-29 2024-06-06 The Johns Hopkins University Aptamer regulated transcription for in-vitro sensing and transduction
CN116170470B (zh) * 2023-02-28 2023-07-04 北京科易为科技有限公司 移液器系统的数据通讯方法及其通讯系统

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060121510A1 (en) * 1998-11-03 2006-06-08 Breaker Ronald R Multidomain polynucleotide molecular sensors
US20030162190A1 (en) * 2001-11-15 2003-08-28 Gorenstein David G. Phosphoromonothioate and phosphorodithioate oligonucleotide aptamer chip for functional proteomics
US20060121466A1 (en) * 2002-06-13 2006-06-08 Amgen Inc. Hammerhead ribozymes
US20050019916A1 (en) * 2003-04-14 2005-01-27 Stojanovic Milan N. Cross reactive arrays of three-way junction sensors for steriod determination
MX2007005491A (es) * 2004-11-08 2007-09-27 Univ Yale Diseno de compuesto basado en la estructura que involucra riboconmutadores.
SG174103A1 (en) * 2007-05-29 2011-09-29 Univ Yale Riboswitches and methods and compositions for use of and with riboswitches
WO2012021554A1 (en) * 2010-08-09 2012-02-16 Yale University Cyclic di-gmp-ii riboswitches, motifs, and compounds, and methods for their use
US8383794B2 (en) * 2010-10-08 2013-02-26 Li Niu Conformation-selective nucleic acid inhibitors of AMPA glutamate receptors
US20120248666A1 (en) * 2011-03-30 2012-10-04 Firestone Industrial Products Company, Llc Gas spring and damper assembly and suspension system including same
US10294478B2 (en) * 2011-08-16 2019-05-21 The Research Foundation For The State University Of New York Aptamer modulators of estrogen receptors
US9664676B2 (en) * 2013-09-06 2017-05-30 Cornell University RNA sequences that induce fluorescence of small molecule fluorophores
CN104293793B (zh) * 2014-07-24 2018-05-18 江南大学 一种特异识别t-2毒素的寡核苷酸适配体

Also Published As

Publication number Publication date
EP3551755A4 (en) 2020-06-24
JP2023093572A (ja) 2023-07-04
JP2020504096A (ja) 2020-02-06
MY205553A (en) 2024-10-25
IL267216B2 (en) 2025-04-01
US20200208142A1 (en) 2020-07-02
AU2017378078B2 (en) 2024-06-13
EP3551755A1 (en) 2019-10-16
KR102612226B1 (ko) 2023-12-12
PH12019501302A1 (en) 2019-10-28
EA201991446A1 (ru) 2020-03-03
JP7418210B2 (ja) 2024-01-19
CN110462039A (zh) 2019-11-15
BR112019012012A2 (pt) 2019-10-29
WO2018111745A1 (en) 2018-06-21
AU2017378078A1 (en) 2019-07-25
KR20190100227A (ko) 2019-08-28
IL267216A (en) 2019-08-29
CA3056218A1 (en) 2018-06-21
IL267216B1 (en) 2024-12-01
US20220170009A1 (en) 2022-06-02

Similar Documents

Publication Publication Date Title
MX2019006825A (es) Uso de andamios biológicos de arn mediante selección in vitro para la generación de moléculas de aptámeros, con robusta capacidad de unión a biosensores genéticamente codificables.
Shen et al. Biomimetic membranes: A review
CO2019006541A2 (es) Administración viral de neoantígenos
SA520411173B1 (ar) Pd-l1 عوامل ربط ترتبط بـ واستخدامها cd137
MX2022006652A (es) Proteinas de capside modificadas para un suministro mejorado de vectores de parvovirus.
ZA202001294B (en) Multispecific antibody
MY181693A (en) Dual quencher probes
EP3325665A4 (en) AMPLIFICATION PROCEDURE FOR NUCLEIC ACID SEQUENCES
CO7151531A2 (es) Anticuerpos e inmunoconjugados contra ly6e y métodos de uso
MX2015007575A (es) Construcciones de anticuerpos de adn y metodo para utilizarlas.
MA37619A1 (fr) Anticorps anti-fcrn
EA201590171A1 (ru) ИММУНОКОНЪЮГАТЫ, СОДЕРЖАЩИЕ АНТИТЕЛА К CD79b
DK3328892T3 (da) Bispecifikke antistofkonstruktioner, der binder egfrviii og cd3
SI4141032T1 (sl) Kombinirano zdravljenje z bispecifičnimi molekulami, ki vežejo antigen, ki aktivira T celice, ter antagonisti, ki vežejo os PD-1
EP3432918A4 (en) DNA ANTIBODY CONSTRUCTS AND METHOD FOR USE THEREOF
CR20170240A (es) Anticuerpos anti-interleucina-33 y sus usos
EA201590173A1 (ru) Иммуноконъюгаты, содержащие антитела к cd22
MX2021011584A (es) Anticuerpos que penetran en celulas.
EP3452107A4 (en) DNA MONOCLONAL ANTIBODIES AGAINST CHECKPOINT MOLECULES
EP3591051A4 (en) METHODS OF REPLICATION OR AMPLIFICATION OF CIRCULAR DNA
AR104604A1 (es) ANTICUERPOS ANTI-FcRn
MA39096B1 (fr) Anticorps spécifiques à fcrn
DK3331553T3 (da) Hidtil ukendte, antihumane gpvi-antistoffer og anvendelser deraf
MX390053B (es) Metodos de evaluacion genomica en ganado.
MX2016014359A (es) Antigeno e de hepadnavirus marcado y su uso en el tamizado de sustancias antivirales.